As illustrated in Fig. 7: firstly, UA could mitigate neuroinflammation and enhance PD symptomatology by inhibiting the activation of extracellular signal-regulated kinase 1/2 (ERK1/2), thus attenuating ERK1/2-mediated inflammatory pathways. Here, MAPK3 is linked to Parkinson disease.